drugset / Trial / NCT00002970
506U78 in Treating Patients With Refractory Hematologic Cancer
NaSingle-groupOpen-labelTreatment
Summary
Phase II trial to study the effectiveness of 506U78 in treating patients with recurrent or refractory hematologic cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 1997-06
- Primary completion
- 2005-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelarabine | Small molecule | — | Intravenous |
| Background | Cytarabine | Small molecule | — | Other |
| Background | Hydrocortisone | Other / unclassified | — | Other |
| Background | Methotrexate | Small molecule | — | Other |